Free U.S. Shipping Orders Above $200
Home / Shop / Tesamorelin
Tesamorelin

Tesamorelin

$64.99
Dosage

Tesamorelin — Research Peptide

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog commonly studied in laboratory settings for its interaction with pituitary signaling pathways, growth hormone secretion mechanisms, and metabolic regulatory processes. Structurally derived from endogenous GHRH, Tesamorelin has been investigated for its role in peptide-mediated endocrine signaling and cellular communication pathways.

Scientific literature has explored Tesamorelin in research involving growth hormone regulation, insulin-like growth factor-1 (IGF-1) signaling, metabolic pathway analysis, and endocrine system function. Studies have examined how Tesamorelin interacts with GHRH receptors and influences pulsatile growth hormone signaling in experimental models.

Published studies have investigated Tesamorelin in areas related to metabolic signaling, body composition research, cellular energy regulation, and peptide-mediated biochemical pathways. Additional laboratory research has explored its effects on endocrine communication mechanisms and hormone signaling processes.

This compound is supplied for qualified laboratory research and analytical purposes only.

Product Details

Product Name: Tesamorelin
Form: Lyophilized peptide powder
Grade: Research use only
Application: Laboratory research and analytical testing only
Storage: Store in a cool, dry place under proper laboratory storage conditions.

Research Areas

This compound may be used in research related to:

  • Growth hormone-releasing hormone (GHRH) pathway studies
  • Pituitary and endocrine signaling research
  • IGF-1 and metabolic signaling investigation
  • Peptide-mediated cellular communication analysis
  • Hormonal regulation and biochemical pathway studies
  • Cellular energy metabolism research
  • Molecular and endocrine signaling pathway analysis

Research References

  • Falutz J, Allas S, Blot K, et al. “Metabolic effects of a growth hormone-releasing factor in patients with HIV.” New England Journal of Medicine.
  • Stanley TL, Feldpausch MN, Oh J, et al. “Effect of tesamorelin on visceral fat and metabolic parameters.” JAMA.
  • Thorner MO, Strasburger CJ, Wu Z, et al. “Growth hormone-releasing hormone analogs and endocrine pathway research.” Endocrine Reviews.

Lorem ipsum dolor ist amte, consectetuer adipiscing eilt. Aenean commodo ligula egget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quak felis, ultricies nec, pellentesque eu, pretium quid, sem.

For research use only. Not for human use. Not for animal use. Not for consumption, injection, ingestion, cosmetic use, medical use, veterinary use, or therapeutic application. This product is not intended to diagnose, treat, cure, or prevent any disease. Must be handled only by qualified professionals in a controlled laboratory setting.
0